Detalles de la búsqueda
1.
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?
Blood
; 124(12): 1887-93, 2014 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25102853
2.
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.
Blood
; 119(3): 687-91, 2012 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22128143
3.
Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.
Br J Haematol
; 163(5): 581-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24117042
4.
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials.
Am J Pathol
; 181(5): 1870-8, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22974582
5.
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.
Blood
; 118(17): 4547-53, 2011 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21900193
6.
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.
Blood
; 114(20): 4369-72, 2009 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-19755674
7.
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
Lancet Oncol
; 11(10): 934-41, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20739218
8.
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients.
Haematologica
; 94(11): 1599-602, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19880781
9.
Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response.
Br J Haematol
; 142(5): 766-74, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18637804
10.
Comparison of immunofixation, serum free light chain, and immunophenotyping for response evaluation and prognostication in multiple myeloma.
J Clin Oncol
; 29(12): 1627-33, 2011 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21402611
Resultados
1 -
10
de 10
1
Próxima >
>>